Development of antisynthetase syndrome in a patient with rheumatoid arthritis

Rheumatology International

Volumn 31, Issue 4, 2011, Pages 529-532

  Park, Cheol Kyu ^a   Kim, Tae Jong ^a   Cho, Young Nan ^a   Kim, Il Soo ^a   Lee, Ho Jun ^a   Lee, Kyung Eun ^a   Park, Seong Chang ^a   Kim, Jong Sun ^a   Park, Dong Jin ^a   Lee, Sung Ji ^a   Seo, Seong Rye ^a   Kim, Jeong Chul ^a   Song, Sang Gook ^a   Lee, Shin Seok ^a   Park, Yong Wook ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Anti Jo 1 antibody; Antisynthetase syndrome; Rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; JO 1 ANTIBODY; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTISYNTHETASE SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE DURATION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HAIR LOSS; HUMAN; INTERSTITIAL LUNG DISEASE; LOW DRUG DOSE; MULTIPLE CYCLE TREATMENT; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MIDDLE AGED; MYOSITIS;

EID: 79954449977     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1222-y     Document Type: Article

References (12)

1. LA Love RL Leff DD Fraser IN Targoff M Dalakas PH Plotz, et al. 1991 A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups Medicine (Baltimore) 70 360 374 1:STN:280:DyaK38%2FmsFOqsA%3D%3D
2. C Marguerie CC Bunn HL Beynon RM Bernstein JM Hughes AK So, et al. 1990 Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes Q J Med 77 1019 1038 2267280 1:STN:280:DyaK3M%2FpsFGhsw%3D%3D (Pubitemid 20370993)
3. E Gomard-Mennesson N Fabien JF Cordier J Ninet J Tebib H Rousset 2007 Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies Ann N Y Acad Sci 1109 414 420 17785330 10.1196/annals.1398.047 1:CAS:528: DC%2BD2sXhtVyjsb%2FJ (Pubitemid 47511384)
4. M Nishikai M Reichlin 1980 Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system Arthritis Rheum 23 881 888 7406938 10.1002/art.1780230802 1:STN:280: DyaL3c3msFehtw%3D%3D (Pubitemid 10040117)
5. A Imbert-Masseau M Hamidou C Agard JY Grolleau P Cherin 2003 Antisynthetase syndrome Joint Bone Spine 70 161 168 12814758 10.1016/S1297-319X(03)00012-5 (Pubitemid 36753467)
6. F Sakai S Noma Y Kurihara H Yamada A Azuma S Kudoh, et al. 2005 Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features Mod Rheumatol 15 173 179 17029058 10.1007/s10165-005-0387-9 (Pubitemid 40983484)
7. JH Ju SI Kim JH Lee SI Lee WH Yoo JY Choe, et al. 2007 Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis Arthritis Rheum 56 2094 2096 17530652 10.1002/art.22666 (Pubitemid 47110410)
8. TW O'Neill PJ Maddison 1993 Rheumatoid arthritis associated with myositis and anti-Jo-1 antibody J Rheumatol 20 141 143 8441147 (Pubitemid 23049199)
9. A Ponyi T Constantin K Danko 2004 Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap Clin Rheumatol 23 371 372 15293105 10.1007/s10067-004-0903-x (Pubitemid 39193800)
10. NE Bowles V Dubowitz CA Sewry LC Archard 1987 Dermatomyositis, polymyositis, and Coxsackie-B-virus infection Lancet 1 1004 1007 2883345 10.1016/S0140-6736(87)92271-9 1:STN:280:DyaL2s3gtVektw%3D%3D (Pubitemid 17057853)
11. PH Plotz 1983 Autoantibodies are anti-idiotype antibodies to antiviral antibodies Lancet 2 824 826 6137652 10.1016/S0140-6736(83)90740-7 1:STN:280:DyaL2c%2Fht1ykug%3D%3D (Pubitemid 13009270)
12. S Ochi K Taniguchi M Nagashima 2009 Leflunomide-induced polymyositis in a patient with rheumatoid arthritis Mod Rheumatol 19 443 446 19526307 10.1007/s10165-009-0181-1